Payers’ Use Of Real-World Evidence For Drug Coverage On The Rise – IMS Health
Executive Summary
A new study by IMS Health shows payers globally are making more drug reimbursement decisions based on real-world evidence – including 25% of more than 100 identified case studies using biopharma industry-generated data.